NORWOOD, Mass. - Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), a $119 million market cap biopharmaceutical company, announced the release of an abstract detailing its Phase 1 clinical study of ...

Ballinrobe Community School celebrated major success at the recent BT Young Scientist and Technology Exhibition held in the ...

Science parks akin to the U.S. biotech hubs of Cambridge ... “There's been a lot of really good, high quality molecules and data that have emerged from China over the last couple of years,” said ...

ViiV Healthcare has secured European Commission approval for its long-acting HIV treatment, Vocabria + Rekambys, for adolescents aged 12 and olde ...

Agenus Inc. , a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research (AACR) IO Annual Meeting that ...

Greenpeace International has filed a lawsuit against U.S. pipeline company Energy Transfer in a Dutch court, the ...

Amber Zheng, Yiqin Zhou, Maureen (Marty) Fromuth, Mahmoud Ghanem, Brendan Lundquist are the five recent Master of Information ...

There are thousands of science societies, so the team decided to focus specifically on ecological and evolution societies. To narrow the data down ... so-called 'research pipeline' that other ...

A 2023 reform has boosted voucher use by 67%, with one-quarter of state scholarships now going to families in the top income ...

PRINCETON, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: FOLD), today announced that two oral presentations and 20 ...

Rondo Therapeutics, a privately held biopharmaceutical immuno-oncology company pioneering the development of next-generation T cell-engaging bispecific antibodies for the treatment of solid tumors, ...